EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieÄquivalenzstudieOpen Access · CC BY 4.0

An Infant Formula with Partially Hydrolyzed Whey and Intact Protein Demonstrates Adequate Growth and Safety: A 6-Month Randomized, Triple-Blind, Controlled Trial

Qianqian Shen iD, Hua Jiang iD, Shuai Mao, Sha Luo, Yanjie Hao, Wenxin Liang, Tingchao He, Lotte Neergaard Jacobsen, Nan Sheng, Jing Yin, Xiaoying Feng, Xiaojiang Jia und 2 weitere

Nutrients · 2026

DOI: 10.3390/nu18050770 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2026. Verfasst von Qianqian Shen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Food Hygiene, School of Public Health, Peking University, Beijing 100191, China. Hauptthemen laut MEDLINE: Infant Formula, Whey Proteins, Child Development, Infant Nutritional Physiological Phenomena. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Arla Foods (Denmark).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Evidence suggests that partially hydrolyzed whey protein promotes appropriate infant growth; however, research on its long-term effects, especially in Asia, remains limited. This study set out to evaluate the effects of an infant formula containing partially hydrolyzed whey and intact protein on infant growth and development.

Methods

This multicenter, triple-blind, randomized non-inferiority trial enrolled healthy full-term infants (≤14 days old). Participants were randomized (1:1) to receive pHF (n = 78) or SF (n = 70) until 6 months of age, with propensity score-matched exclusively breastfed (BF) infants (n = 70) serving as the reference. The primary outcome was daily weight gain. Linear mixed models assessed the association between feeding type and WHO z-scores over time.

Results

Over 6 months, the adjusted mean (SE) daily weight gain (g) was 26.4 (1.27) g/day in BF, 26.0 (1.19) g/day in pHF, and 25.3 (1.27) g/day in the SF group. The adjusted mean difference between pHF and SF was 0.64 g/day (95%CI: −1.55, 2.83), confirming non-inferiority. Growth parameters were comparable between pHF and SF, with WHO z-scores remaining within ± 1 SD of reference standards. Compared with pHF, SF was associated with a slower increase in length-for-age z score (LAZ). While there was no difference between the pHF and BF groups, WAZ increased significantly less in SF vs. BF [−0.34 (95%CI: −0.58, −0.10), p = 0.003]. Gastrointestinal disorders occurred more frequently in the SF group than in the BF group, with no significant difference between the pHF and BF groups.

Conclusions

An infant formula containing partially hydrolyzed whey and intact protein supported adequate growth and was well tolerated during the first six months of life, with growth trajectories comparable to those of breastfed infants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Infant FormulaWhey ProteinsChild DevelopmentInfant Nutritional Physiological PhenomenaHumansInfantWeight GainFemaleMaleInfant, NewbornHydrolysisBreast Feeding

Stichwörter der Autor:innen

breast feedinggrowth and developmentgrowth trajectoriesinfant formulapartially hydrolyzed whey proteinrandomized controlled trial

Substanzen

Whey Proteins

Autor:innen und Institutionen

  • Department of Nutrition and Food Hygiene, School of Public Health, Peking University, Beijing 100191, China.
  • School of Nursing, Peking University, Beijing 100091, China.
  • Maternal and Child Health Hospital of Changsha County, Changsha 410100, China.
  • Department of Neonatology, Shahe People's Hospital, Xingtai 054100, China.
  • Strategic Business Unit Specialized Nutrition, Arla Foods Ingredients Group P/S, Viby J, 8260 Aarhus, Denmark.
  • Junlebao Dairy Joint Laboratory of Breast Milk Science and Life Health, Peking University, Beijing 100191, China.

ORCID-Profile: Qianqian Shen, Hua Jiang, Yvan Vandenplas, Yumei Zhang

Förderung

  • Arla Foods (Denmark)

Zitieren

APA

Shen, Q., Jiang, H., Mao, S., Luo, S., Hao, Y., Liang, W., He, T., Jacobsen, L. N., Sheng, N., Yin, J., Feng, X., Jia, X., Vandenplas, Y., & Zhang, Y. (2026). An Infant Formula with Partially Hydrolyzed Whey and Intact Protein Demonstrates Adequate Growth and Safety: A 6-Month Randomized, Triple-Blind, Controlled Trial. Nutrients. https://doi.org/10.3390/nu18050770

Vancouver

Shen Q, Jiang H, Mao S, Luo S, Hao Y, Liang W, et al. An Infant Formula with Partially Hydrolyzed Whey and Intact Protein Demonstrates Adequate Growth and Safety: A 6-Month Randomized, Triple-Blind, Controlled Trial. Nutrients. 2026. doi:10.3390/nu18050770

BibTeX
@article{Shen2026,
  author = {Shen, Qianqian and Jiang, Hua and Mao, Shuai and Luo, Sha and Hao, Yanjie and Liang, Wenxin and He, Tingchao and Jacobsen, Lotte Neergaard and Sheng, Nan and Yin, Jing and Feng, Xiaoying and Jia, Xiaojiang and Vandenplas, Yvan and Zhang, Yumei},
  title = {An Infant Formula with Partially Hydrolyzed Whey and Intact Protein Demonstrates Adequate Growth and Safety: A 6-Month Randomized, Triple-Blind, Controlled Trial},
  journal = {Nutrients},
  year = {2026},
  doi = {10.3390/nu18050770}
}
Kostenlos starten →